Today, U.S. Markets are closed for Thanksgiving Day.
On Wednesday, Cisco Systems, Inc. (NASDAQ:CSCO)’s shares declined -0.11% to $27.24.
CSCO has the market capitalization of $138.42 billion. The stock has P/B ratio of 2.31 while EPS was $1.87. Institutional ownership of the company was 77.20% while 4.08 billion shares were outstanding. Net profit margin of the Company was 19.30% while its gross profit margin was 60.80%. Share of the company moved below its SMA 50 with -0.51%. ROE ratio was 16.20% while ROI was 10.10%.
The mean estimate for the short term price target for Cisco Systems, Inc. (NASDAQ:CSCO) stands at $30.36 according to 32 Analysts. The higher price target estimate for the stock has been calculated at $37.00 while the lower price target estimate is at $17.00.
Analysts mean recommendation for the stock is 2.30. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Cisco System, Inc. (Cisco) designs and sells lines of products, provides services and delivers integrated solutions to develop and connect networks around the world, building the Internet.
Kinross Gold Corporation (USA) (NYSE:KGC)’s shares dropped -0.52% to $1.93.
KGC has market capitalization of $2.21 billion. Its current ratio was 3.40 while its shares were below its 50 days simple moving average with -0.31%. The company offered earning per share of $-1.41 while its 1.15 billion shares were outstanding. YTD performance of the company was -31.56%. Stock volatility for the week was 6.25% while for the month it was shown at 6.34%.
The mean estimate for the short term price target for Kinross Gold Corporation (USA) (NYSE:KGC) stands at $2.53 according to 22 Analysts. The higher price target estimate for the stock has been calculated at $5.00 while the lower price target estimate is at $1.25.
Analysts mean recommendation for the stock is 2.80. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
Kinross Gold Corporation is a senior gold mining company. The Company is engaged in gold mining and related activities, including exploration and acquisition of gold-bearing properties, the extraction and processing of gold-containing ore, and reclamation of gold mining properties.
At the end of Wednesday’s trade, Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)‘s shares surged 2.68% to $6.52.
So far in 2015, the company has a year-to-date performance of -5.09%. The stock, as of last close, traded 17.48% up from its 52 week low and was -35.25% below its 52 week high. Its latest closing price was -17.90% below the SMA200 while the distance from SMA 50 and SMA 20 was -4.51% and -3.44% respectively.
The mean estimate for the short term price target for Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stands at $8.08 according to 6 Analysts. The higher price target estimate for the stock has been calculated at $11.00 while the lower price target estimate is at $4.50.
Analysts mean recommendation for the stock is 2.40. This number is based on a 1 to 5 scale where 1 indicates a Strong Buy recommendation while 5 represents a Strong Sell.
ARIAD Pharmaceuticals, Inc. is a global oncology company. The Company is engaged in the discovery, development and commercialization of small molecule drug indicated for the treatment of cancer.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.